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CHAPTER 13 
Medical Tourism Facilitators: 
Ethical Concerns about Roles and Responsibilities  
Jeremy Snyder,1 Valorie A. Crooks,2 Alexandra Wright,1 and Rory Johnston,2* 
 
Introduction 
Within the medical tourism industry are a number of key stakeholders – groups and 
individuals who champion the development of the industry, provide services within the 
industry, use the services of the industry, and/or are directly or indirectly impacted by the 
industry - who contribute to its expansion. One such group is facilitators, private agents who 
broker medical travel and foreign care arrangements between patients and destination 
facilities but are not employed by these facilities.1 Key to this element of the medical tourism 
industry is the Internet; facilitation companies in many countries have a strong web presence 
and rely primarily on websites (and secondarily on word-of-mouth) to advertise their 
services.1-4  
Medical tourism brokers’ responsibilities toward medical tourists can include securing 
travel and accommodation needs, suggesting and booking facilities and surgeons abroad, 
contacting destination clinics, overseeing translation of medical records, arranging for tourist 
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activities, and transferring medical records.5 These brokers can play an essential role in 
facilitating communication, providing information, and securing overall quality control by 
assessing the reputability and reliability of international facilities.3 It appears, however, that 
only a fraction of medical tourists actually use the services of brokers.1 Brokers themselves 
have indicated this, noting that patients wanting to go abroad for care sometimes seek them 
out as an informational resource even though they never actually intend to book care through 
them.3 
There is no single business model for medical tourism facilitators. This is perhaps not 
surprising given the range of roles and responsibilities they may take on. Some facilitators 
refer patients to a number of countries, while others refer only to one or two trusted 
international facilities.3 Some arrange care for hundreds of medical tourists each year, while 
others do so for less than twenty clients per year.3 Some specialize in arranging care abroad 
for a particular procedure or group of procedures, while others have no stated limitations on 
procedures for which they are willing to arrange care.3 These are but a few of the fundamental 
differences between medical tourism facilitators’ business practices. While some facilitators 
view themselves as patient advocates and change agents, playing an involved role in patient 
care coordination and putting forth calls for domestic health system reform, others see their 
roles and responsibilities as much more limited, primarily focusing on the logistics of 
securing care abroad.5 In general, medical tourism facilitation remains relatively fluid and 
undefined as a profession. There is also no overarching professional organization providing 
mandatory monitoring of facilitators and their practices.6 
 In this chapter we review ethical concerns that have been raised in the medical tourism 
literature with regard to the specific roles and responsibilities of medical tourism facilitators, 
including as they relate to business practices. We also examine the evidence available in the 
scholarly literature to support or refute these concerns. As we outline below, most of the 
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scholarly literature that offers primary data-based insights on facilitators’ roles and practices 
uses facilitator websites, interviews with facilitators, or legal cases as empirical sources.  We 
compare the ethical concerns raised in the ethical and legal literature to the empirical findings 
about facilitators’ roles and practices in reviews of facilitator websites, interviews, and legal 
cases to identify which ethical concerns have been borne out thus far. Finally, we use the gaps 
that emerge between these two bodies of scholarly literature to assess proposed regulation 
(i.e., the creation of an institutional framework, such as laws or operating regulations) of 
medical tourism facilitators and to identify future research directions. In doing so, we aim to 
present the current state of knowledge about the ethical issues raised by medical tourism 
facilitation and guide continued research on this topic. 
Existing ethical concerns about medical tourism facilitators 
Through our review of the ethical and legal literature about medical tourism, we identified 
five areas of ethical concern most commonly discussed about the roles and responsibilities of 
facilitators.  These areas are: 1) facilitator training and accreditation (i.e., facility- or 
organizational-level systems for enacting and assessing standards); 2) facilitator conflicts of 
interest; 3) transparency and patients' consent to risks; 4) problems with continuity of care and 
follow up care; and 5) liability for harms. In the remainder of this section of the chapter we 
outline the scope of the ethical concerns in each of these areas and then examine the extent to 
which the empirical medical tourism literature confirms that these problems actually are 
occurring. Table 1 provides an overview of the data available in the empirical sources we 
discuss. 
 
Table 1. Overview of Empirical Sources Reviewed 
Source Title Authors Year Source(s) of Data 
The Potential for Bi-lateral Agreements in 
Medical Tourism: A Qualitative Study of 
Stakeholder Perspectives from the UK and India 
Alvarez, 
Chanda, 
Smith 
2011 30 medical tourism stakeholder 
interviews (10 in United 
Kingdom, 20 in India), of 
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which 2 were facilitators 
Medical Travel Facilitator Websites: An 
Exploratory Study of Web Page Contents and 
Services Offered to the Prospective Medical 
Tourist 
Cormany, 
Baloglu 
2011 website review (reviewed 57 
websites of facilitators--24 N. 
American, 11 Asian, 8 
European, 8 Central and S. 
American, 6 African) 
Patients Without Borders: The Emerging Global 
Market for Patients and the Evolution of Modern 
Health Care 
Cortez 2008 legal review (including 
consideration of specific 
facilitator websites) 
An Industry Perspective on Canadian Patients’ 
Involvement in Medical Tourism: Implications 
for Public Health 
Johnston, 
Crooks, 
Adams, 
Snyder, 
Kingsbury 
2011 12 interviews with Canadian 
medical tourism facilitators 
Systematic review of web sites for prospective 
medical tourists 
Lunt, Carrera 2011 website review (reviewed 50 
English language websites of  
facilitators) 
Framing Medical Tourism: An Examination of 
Appeal, Risk, Convalescence, Accreditation, and 
Interactivity in Medical Tourism Web Sites 
Mason, 
Wright 
2010 website review (reviewed 66 
websites of United States-based 
facilitators) 
International medical travel and the politics of 
therapeutic place-making in Malaysia 
Ormond 2011 49 medical tourism stakeholder 
interviews in Malaysia, of 
which 7 were facilitators 
Risk Communication and Informed Consent in 
the Medical Tourism Industry: A Thematic 
Content Analysis of Canadian Broker Websites 
Penney, 
Snyder, 
Crooks, 
Johnston 
2011 website review (reviewed 17 
websites of Canadian 
facilitators) 
The ‘Patient’s Physician One-Step Removed’: 
The Evolving Roles of Medical Tourism 
Facilitators 
Snyder, 
Crooks, 
Adams, 
Kingsbury, 
Johnston 
2011 12 interviews with Canadian 
medical tourism facilitators 
Selling Medical Travel to US Patient-Consumers: 
The Cultural Appeal of Website Marketing 
Messages 
Sobo, 
Herlihy, 
Bicker 
2011 website review (reviewed 27 
websites of United States-based 
facilitators) 
Medical Tourism: Protecting Patients from 
Conflicts of Interest in Broker’s Fees Paid by 
Foreign Providers 
Spece 2010 legal review (including 
consideration of specific 
facilitator websites) 
 
Facilitator Training and Accreditation 
The global nature of medical tourism complicates patients’ abilities to assess the credentials 
of the hospitals, physicians, and other health workers they may encounter in distant facilities. 
Patients often must navigate a bewildering array of regulatory environments, accreditation 
systems and facilities in deciding whether and where to seek care. This problem extends to 
distinguishing the quality of medical tourism facilitators, upon whom patients may depend for 
help in guiding their medical decision-making.3 So while facilitators might, in principle, help 
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patients to overcome difficulties in assessing the quality of the care they will receive abroad, 
patients may first find it difficult to assess the quality of facilitators and facilitation companies 
themselves.  
 While some facilitators specialize in and have detailed knowledge about specific 
destinations, there is no limit to the destinations – and thus different regulatory and 
accreditation environments - to which they may direct their clients.6 Similarly, while some 
facilitators have a medical background, such training is not required for entry into the 
profession. It has been speculated that many facilitators come from a tourism background, 
with experience booking vacations, flights, and other tourist services, but lack the background 
to help facilitate  medical tourists' medical needs.7 This lack of training is part of a wider area 
of ethical concern regarding facilitators’ roles and responsibilities, namely the lack of 
universal standards of training and accreditation for members of this profession and, more 
strikingly, a lack of barriers to entering the facilitation industry, including any requirement 
that facilitators receive training or accreditation.7 Meanwhile, facilitators can play a 
substantial role in patient decision-making about the care they will receive. Facilitators who 
see giving medical advice as falling within their roles may suggest certain medical 
interventions, advise patients on the safety and outcomes of these interventions, and help 
guide, with substantial advice and influence, patients' health care decisions. Consequently, 
there is danger that potential medical tourists will make treatment decisions without the 
benefit of direct consultation with medical professionals and rely instead on the 
recommendation of facilitators who may lack medical training, or even clear standards for 
what information they should provide to patients.  
There has been little consideration of how aware medical tourists are about facilitators' 
level of training. If this awareness is minimal, they are likely not in a position to judge the 
quality of advice that they receive from these individuals. Facilitators have the word ‘medical’ 
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in their titles, make seemingly informed claims about the success rates of procedures and 
quality of care in specific facilities and by specific physicians, and take on the role of patient 
advisor and even advocate.1,5 These roles may easily confuse patients, thereby leading them to 
put unjustified weight on facilitators’ advice. If patients are not willing to discuss their 
decision to seek medical care abroad with their own physicians (or even other members of 
their social networks) or do not have access to a physician due to financial constraints, then 
the facilitators' perspectives will not be balanced by other, less financially interested views.  
Just as other medical providers, including hospitals, physicians, and private clinics, are 
regulated to instil practices that do not harm the health and safety of patients, it has been 
argued that medical tourism facilitators should be similarly regulated based on some kind of 
accreditation standards.6 The content of these accreditation standards are still a matter of 
debate; for example, it is not immediately clear whether facilitators should be required to 
obtain some degree of medical training or whether requiring limits on the advice they give to 
clients would be sufficient to protect clients’ interests. Without accreditation requirements, as 
is presently the case, there are no restrictions on who can take on the role of facilitator or 
repercussions for those who violate professional norms. 
In a content analysis of Canadian facilitation company websites, Penney et al. 
observed that the websites did not consistently refer to a single facilitator organization that 
represents a comprehensive monitoring body.1 This was confirmed in Mason and Wright’s 
analysis of facilitator websites, which  found that website logos that appeared to signify 
quality were typically branding devices rather than evidence of facilitator certification.8 Of the 
websites Penney et al. examined, 35.3% contained logos or representations of various 
organization memberships, but only rarely were these evidence of facilitator certification (i.e., 
individual-level training and credentialing) by any regulatory organization. Although some 
sites referred to external accreditation bodies, those bodies' reputability and assessment 
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standards are not always clear to medical tourists. This particular analysis also found that the 
sites generally did not indicate which of the hospitals they recommended were accredited, 
although 52.9% of websites provided information on physicians and their credentials.1 
 Mason and Wright reported that 29.3% of the reviewed sites gave evidence of some 
form of accreditation for preferred destination hospitals, such as indications that the facilities 
have met the standards of the  Joint Commission International (JCI) or the International 
Organization for Standardization.8 JCI accreditation has been used as a marker of quality and 
safety in the medical tourism industry and is often highly sought by facilities seeking to attract 
international patients.6 But the display of hospital accreditation information on facilitator 
websites may confuse potential clients. Medical tourists may feel confident accepting a 
facilitator’s services based on the mistaken belief that a preferred destination facility’s 
accreditation also applies to the facilitator and/or facilitation company when, in fact, it says 
nothing about the facilitator's qualifications or knowledge.1 
Facilitator Conflicts of Interest 
Medical tourism is characterized by patients arranging for private medical services that they 
typically pay for out-of-pocket.3  As we explained earlier, facilitators are private operators 
who are paid in exchange for the services they provide to those seeking this private care. But 
patients may not be aware of how much or in what manner facilitators are paid, since patients 
may not pay directly for facilitators’ services. These services may be covered by referral fees 
paid for by the destination hospital or as part of an overall ‘package deal’ that does not 
include a detailed cost breakdown. Consequently, the financial structures of medical tourism 
as they relate to facilitators’ involvement may be opaque to individual patients. 
 Because medical tourism facilitators receive fees to arrange for medical services, there 
is potential for a conflict between the interests of the facilitators and those of patients. While 
some facilitators receive fees directly from their clients, and so align their interests more 
 
 
 
Medical Tourism  
Research Group 
 
- 8 - 
 
directly with those of the client, other facilitators receive fees or other benefits from medical 
facilities or physicians abroad with whom they book procedures.9 Thus, in some cases, the 
facilitator has an incentive to book procedures independent of any benefit to the patient. This 
conflict of interest can take the form of supplier-induced demand, in which the facilitator 
encourages the client to purchase specific forms of medical care, introduces the client to new 
options for care, or even alerts the client to previously unknown medical conditions or 
perceived medical needs, all while receiving payment from providers for the provision of 
these services.10 
 The potential for conflict of interest in medical tourism facilitators’ business practices 
extends to facilitators recommending or encouraging clients to obtain procedures that are 
unavailable or illegal in their home countries. If facilitators receive booking fees, they have an 
incentive to encourage their clients to receive these procedures regardless of whether they are 
legal in the client's home country. The international dimension of medical tourism allows 
facilitators to promote and aid their clients in escaping the legal jurisdiction of their home 
countries, which undermines the ability of countries to regulate access to medical care at 
home.11 While such regulations may exhibit ethically problematic paternalistic attitudes, or 
state enforcement of public morality on individuals (e.g., in reproductive decisions), states do 
have a legitimate interest in regulating the medical care provided to citizens to promote 
patient safety and public health.12 In some cases, states with high regulatory thresholds for 
patient safety will make certain treatments unavailable out of concern for efficacy, side 
effects, or other threats to health. By enabling patients’ access to these treatments outside of 
domestic regulatory frameworks, facilitators can expose clients to risks that they would not 
have faced in their home health systems.6 At the same time, access to unavailable, illegal, or 
experimental treatment such as experimental stem cell therapies can be highly desirable for 
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patients who are well informed about their associated uncertainties and risks; and in some of 
these cases, facilitators are crucial to enabling such access. 
 Unfortunately, there is little empirical evidence to support or refute claims that 
medical tourism facilitators face conflicts of interest in enacting their roles and 
responsibilities. In a legal review, Spece found that information about facilitators’ fees is 
generally not provided up-front to clients.9 As a result, some clients may assume that 
facilitators are working on a non-profit basis. The likelihood for misunderstandings regarding 
facilitators’ referral fees received from medical tourism providers and fee structures charged 
to patients can be heightened by clients’ unfamiliarity with medical referral fees, in light of 
the prohibition of referral fees in some domestic health care contexts. Johnston et al. 
confirmed this in their study, in which Canadian facilitators speculated that Canadian patients 
may find the notion of paying a facilitator to assist with booking and coordinating care to be 
off-putting since Canada's public health care system does not require citizens to pay out-of-
pocket for any aspect of necessary medical care.3 
Transparency of and Consent to Risks 
Medical tourism has been associated with a range of risks to the patient, including deep vein 
thrombosis (blood clots) due to flying soon after surgery, exposure to infectious disease, poor 
quality of care, and the creation of a discontinuous medical record.13 Informed consent 
requires that patients receive and comprehend information pertaining to treatment options, 
success rates, and risks of complications prior to undergoing care. Patients may not be aware 
of the risks associated with medical tourism, and therefore may not be able to give fully 
informed consent to be exposed to these potential complications.1 
 Facilitators’ websites are thought to be a key, initial source of information about 
medical tourism for many patients.1-4 These websites serve as a means of advertising 
facilitation services to potential clients, and so there is likely to be a great incentive to inform 
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people of the potential benefits of medical tourism and to assuage any fears associated with 
traveling abroad for medical care. These positive messages may not be balanced against 
information about the risks inherent in medical travel, so patients may not receive the 
information necessary to give informed consent to these risks. Many patients opt for medical 
tourism based on the lower price of the treatments offered abroad.13 Since cost savings are 
often associated with inferior quality,14  facilitators’ websites may feature an abundance of 
quality assurance messages as an anticipatory strategy to head-off potential clients’ concerns 
about whether these lower costs reflect poor quality.7 
Facilitators’ use of branding techniques in advertising their services, including noting 
that physicians at preferred destination facilities have trained in North America and Europe, 
and partnering with internationally recognized hospital and university brands, can help to 
reassure patients about the quality of care abroad. Similarly, use of accrediting agencies like 
the JCI may signal quality and safety to potential customers. Advertising high staffing levels 
and excellent customer service abroad also helps to assuage the concerns of potential medical 
tourists. Facilitators’ references in their promotional materials to state-of-the-art medical 
devices and technologies available in destination hospitals counter concerns that lower levels 
of economic development in host countries mean lower standards of care and less 
technologically advanced medical equipment.7 Again, these messages reflect facilitators’ 
concerns with reassuring medical tourists about the quality of care received abroad, and may 
not accurately represent the risks associated with medical travel. 
 Since facilitators will be motivated to communicate the potential benefits of medical 
tourism, it is possible for a medical tourist to book care through a facilitator and never receive 
a comprehensive list of the risks and dangers associated with this practice; in fact, the patient 
may only receive an account of the high quality of the care available abroad or at a specific 
facility. The accuracy of this information may be very difficult for the medical tourist to 
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verify. Because norms and legal requirements for informed consent vary by country, the 
patient may have expectations for receiving information about risks that are not shared by the 
facilitator.7 This problem is exacerbated by the lack of a single set of professional norms 
about communicating risks in the industry and an overall lack of oversight. 
 In reviews of facilitator websites, risk information – which is necessary for informed 
consent - has been found to be limited. For example, Penney et al. found that only 17.6% of 
Canadian medical tourism facilitator websites addressed possible risks and negative 
outcomes, and those that did most often did so in the ‘facts’ or ‘disclaimer’ pages.1 Mason 
and Wright also found that websites rarely addressed risks and concerns on their main pages. 
Their study found only 4.9% of websites addressed postoperative care, 1.1% legal recourse, 
2.2% complications, and 2.2% procedural risk.8 An additional study found 16% of reviewed 
facilitator websites mentioned possible risks, but these risks were again consistently 
downplayed in favor of positive outcomes and benefits of medical travel.15 Sobo et al. 
observed the theme of a “worry free experience” was particularly evident among medical 
tourism websites. Prospective clients were depicted as empowered to take control of their own 
medical care, with the companies’ facilitators being available to assist. Risks were often 
addressed in ‘Terms and Conditions’ pages of websites.16 These reviews confirm that, 
“[d]espite great importance of postoperative care, procedural risk and potential medical 
complications when making informed decisions about undergoing a medical procedure, the 
issues appear to be discussed in limited ways, if at all, on the websites”.8(p.173-174) They also 
show that discussion of risk is rarely given ‘front-page’ coverage on these websites. 
Facilitators are commonly focused on increasing patient confidence and the 
attractiveness of medical tourism destinations in terms of quality, experience, and price.1 To 
heighten patient confidence, facilitators usually focus on statements of accreditation, training 
and experience of physicians, statements of advanced technology used in the hospitals, patient 
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testimonials and enjoyable environments and tourist activities.1,16 Facilitators’ marketing 
materials consistently demonstrate an emphasis on the likely benefits of seeking treatment 
abroad. As such, there is a focus on characterizing positive experiences, benefits and 
outcomes of medical tourism. Penney et al. found that any mention of risk in facilitators’ 
websites was carefully worded to emphasize the unlikelihood of negative outcomes in order to 
maintain a generally positive message. Some websites are careful to remind patients that 
similar risks occur when seeking medical treatment in their own country, which is another 
strategy for minimizing risk messages in marketing materials.1 
Problems with Continuity of Care and Follow-Up Care 
Medical tourism can undermine both informational continuity of care (i.e., the maintenance of 
a continuous and complete medical record) and access to care following treatment.13 When 
medical tourism involves international travel, medical records must be transferred between 
countries. The geographical, cultural, and linguistic distances involved in these transfers may 
complicate continuity of care; the patient’s medical records may become discontinuous, 
different groups of caregivers may have difficulty communicating with one another, or the 
patient may be subjected to multiple, potentially conflicting standards of care. Similarly, the 
self-directed nature of medical tourism means that patients may have difficulty accessing 
follow-up care, including for unexpected complications. The patient’s domestic care providers 
may be unfamiliar with the care received abroad or reluctant to provide follow-up care out of 
a concern for legal liability for complications arising from this care--if the patient has access 
to care at home at all. 
 Facilitators may not have the capacity or background necessary to help patients 
arrange for continuity of care and follow-up care. Facilitators may not inform their clients of 
the need to work with their home country physician to arrange for medical record transfer and 
follow-up care if needed. They may not be aware of the need to take these steps, or might be 
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concerned that emphasizing these care coordination logistics will detract from the appeal of 
their services.7 Depending on the facility, there may or may not be international patient 
coordinators (i.e. staff employed by the destination facility to oversee the off- and on-site 
logistics of treating international patients) with which the facilitator can work to ensure 
continuity of the patient’s care.17 In some cases, attempts to facilitate continuity of care are 
limited to suggestions that patients communicate with their home country doctors before and 
after receiving care abroad.17 Patient-initiated conversations of this kind can however be 
limited if patients are ill-informed about the care they will be receiving abroad or hesitant 
about speaking with their regular physicians about leaving the country for care because they 
fear that the physician will disapprove.3 Moreover, patients may not be aware of the potential 
expenses associated with receiving follow-up care upon return home, further complicating 
coordinating after-care.17 In short, there is no guarantee that patients seeking care abroad will 
consult with a physician before or after travel or that facilitators will aid them in doing so.6 
Empirical studies presenting the findings of interviews with facilitators show that their 
roles in arranging follow-up care vary greatly.3,5 Johnston et al. recorded a diverse spectrum 
of facilitator approaches to follow-up care. Some interviewees reported arranging follow-up 
care by request of the client only. Other interviewees frequently contacted clients upon return 
home from medical care abroad to discuss follow-up arrangements.3 Facilitators who 
demonstrated the most involvement in follow-up care reported only accepting clients once 
such care had been secured. Even when facilitators want to take a role in arranging follow-up 
care, their efforts may be restricted in cases when clients’ regular physicians do not support, 
or even openly disapprove of, the pursuit of care abroad and thus decline to provide the 
necessary tests or referrals.3,5 
In a content analysis of 17 websites, Penney et al. found that facilitation companies 
claimed a wide variety of responsibilities regarding the transfer of medical records and 
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coordination of follow-up care. Some websites clearly stated that the facilitator has no role in 
monitoring patient care upon arrival home. Others offered a range of services, including 
“arranging phone calls between the patient and specialist abroad, having report sent to home 
physician, organizing rehabilitation, telehealth consultations, and answering questions”1 
However, whether these services would require additional fees or specific requests was 
typically not made clear. Additional website analyses support the findings of Penney et al. 
that follow-up care is not consistently addressed. For example, Lunt and Carrera found that 
although pre-operative consultations were often offered to potential patients, only 10% of 
websites addressed follow-up care.15 Mason and Wright found only 4.9% of websites 
addressed follow-up care on the main page of their site, with 18.2% addressing follow-up care 
on other pages.8 
Legal Liability for Harms 
When patients seek care abroad, they may be subjected to unfamiliar legal environments. 
Legal protections for patients and medical liability standards differ greatly from jurisdiction to 
jurisdiction. Low malpractice insurance costs have been cited as one factor allowing some 
medical tourism destinations to offer less expensive care,18 but patients may find it 
challenging to factor the value of decreased malpractice protection into their decision-making. 
Facilitators can help patients navigate these issues, but they too inhabit a murky international 
arena complicated both by the relatively unregulated status of medical tourism facilitation and 
the international dimension of the practice. 
 Some facilitators try to insulate themselves from the legal risks of medical tourism--
including suits for malpractice, poor quality of care, or any complications that might arise 
from seeking medical care abroad--by distancing themselves from actual medical provision, 
and instead framing themselves as merely facilitating contact with medical facilities and 
physicians abroad and arranging for travel to these facilities.7 Then if complications arise 
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from the care provided, the responsibility for these problems theoretically would be shifted to 
the physician and medical facilities abroad instead of the facilitators themselves.7 In this way, 
if facilitators simply provide clients with information and contacts, along with a warning to 
beware of the complications that may arise from receiving medical care abroad, patients take 
on the responsibilities for the outcomes of their own decisions.19 
Facilitators' attempts to limit their own liability sometimes take the form of statements 
warning patients that the facilitator has no legal liability for malpractice or complications 
arising from treatment received abroad or dissatisfaction with the care received. In other 
instances, facilitators require clients to sign contracts that waive the facilitator's legal liability 
in the event of complications.7 When this occurs, the facilitator not only warns patients that 
they are on their own when risking medical treatment abroad, but also creates a legal barrier 
against seeking redress from the facilitator. While facilitators may encourage patients to seek 
legal redress from their medical providers abroad, doing so is problematic in two respects. 
First, pursuing a legal course of action abroad may be very expensive and difficult. Doing so 
requires navigating a foreign legal system, possibly using a language other than the patient’s 
own.20,21 If the patient is required to return to the country where the care was received in order 
to pursue damages, this creates additional burdens and costs. Second, adequate legal recourse 
may not even be available to the patient if the host country has limited medical malpractice 
protections for patients.17,21 For a more detailed discussion of the issues surrounding legal 
liability in medical tourism, see Chapter 9 
Interviews with Canadian facilitators show that they emphasize to clients that they are 
not medical professionals, and are instead offering information and referrals that patients have 
requested.5 In this sense, facilitators do not view themselves as being responsible for adverse 
outcomes that occur as a result of patients acting on the information or referrals. Some 
facilitators do perform certain actions that could help lessen the risk of liability issues and 
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patient complications. For instance, one facilitator reported visiting potential destination 
facilitates to see, first-hand, if the facilitator would feel comfortable referring patients there.5 
However, since facilitators lack standardized professional training, their capacity to discern 
quality medical locations from unsafe ones is questionable. In website analyses, very few 
facilitator sites addressed issues of legal recourse for patients. For example, Mason and 
Wright found only 6.1% of websites that they examined addressed legal concerns,8 while Lunt 
and Carerra reported that three of the five sites they examined stated that it was the surgeon’s 
responsibility to address post-operative complications.15  
Discussion 
Our review of ethical concerns tied to the practice of medical tourism facilitation and the 
emerging body of empirically-based research on facilitators confirms, gives context to, and 
enhances our understanding of certain of these ethical concerns. At the heart of these concerns 
is the pressing question that many health systems confront: who holds responsibility for 
managing patient care across the continuum? As we have emphasized above, in the case of 
medical tourism, this continuum extends across countries, legal systems, regulatory 
approaches, and sometimes even languages. 
It is clear that potential medical tourists face challenges in their informed decision-
making. Reviews of facilitator websites consistently show that patients are not made 
sufficiently aware of the risks associated with medical tourism through these sources alone. 
As these websites are initial and formative sources of information, this lack of information 
raises questions about patients’ ability to give fully informed consent to face these risks. Other 
information gaps undermine informed decision-making as well. Should decisions be based 
solely on publicly-available information through facilitator websites, potential medical 
tourists are likely to be confused about facilitators’ pay structures, among other factors. 
Moreover, reviews of facilitator websites give evidence that most do not offer clear guidance 
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on the legal protections afforded to medical tourists if they choose to travel abroad for care. 
Statements and waivers of facilitator liability vary among websites and patients are not likely 
to be in a position to judge the enforceability of these waivers, particularly if they have not yet 
been tested in court. Moreover, these websites lack information on the variability of 
malpractice protections in host countries, further compromising patients' ability to make 
informed decisions.  
The lack of a requirement for accreditation reinforces ethical concerns around the 
roles and responsibilities of medical tourism facilitators. For example, our review 
demonstrated a lack of clear protocols for providing follow-up care and ensuring 
informational continuity of care, a problem due in part to a lack of standardization among 
facilitators. While some facilitators oversee follow-up care for their clients and facilitate 
continuity of care, the treatment of these issues on facilitators’ websites suggests the quality 
and scope of these services is uneven. The lack of accreditation undermines patients’ ability to 
assess facilitators’ training and qualifications. While symbols of accrediting agencies and 
other signifiers of quality were common on facilitator websites, they generally did not pertain 
to accreditation of the facilitators themselves. This can be misleading or confusing for 
medical tourists attempting to evaluate facilitators.  
 However, our review of the literature on medical tourism facilitators shows that a 
number of commonly-cited ethical concerns have yet to be evidenced in practice. For 
example, while concerns have been raised that payments from destination facilities to 
facilitators for referrals creates a potential conflict of interest and may negatively impact 
patient care or motivate unnecessary or overly expensive treatments, we do not yet have 
evidence of whether or how this conflict of interest has influenced facilitators' 
recommendations for care. While the financial incentive referrals create may work against 
patients’ interests, facilitators also have an interest in developing and maintaining a reputation 
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for quality service and satisfied customers that may outweigh those incentives. Furthermore, it 
is difficult to assess the legal vulnerability of patients given the lack of case law around 
facilitator liability waivers. While the findings of website review studies make us suspect that 
the content of these waivers is variable, we do not have access to the content of these 
statements since they are generally not made public. We also do not know how common 
signed waivers are in the industry. Finally, evidence of the negative health impacts of 
engaging in medical tourism and of gaps in continuity of and follow-up care is lacking. While 
anecdotes of complications emerging from medical tourism are common and alarming, as are 
examples of problems with continuity of and follow-up care, more data are needed in order to 
identify and assess trends. Importantly, complications and risks created by medical tourism 
are likely to vary by procedure and location, making it difficult to issue blanket statements 
about the safety of this practice. 
The ethical concerns associated with medical tourism facilitation highlight the need 
for greater regulation and transparency.6,22 The emerging literature on facilitators clearly 
supports the need for greater transparency to help patients understand the risks medical 
tourism entails, as well as facilitators’ potential for conflicts of interest.4 Facilitators could 
promote  transparency by fully disclosing the source and amount of their fees and by 
providing more information about the risks of medical tourism on their websites.9 Requiring 
facilitators to receive training and accreditation could help ensure that facilitators provide this 
information about risks and funding sources to potential patients. 5,6 An accreditation process 
could also help to provide uniform procedures for providing medical tourists with better 
continuity and follow-up care. Other proposed regulations, including restrictions on 
facilitators' contracts, requirements for travel insurance, patient compensation for malpractice, 
and restrictions on the procedures that facilitators can advertise6 are less directly supported by 
the existing empirically-based literature. Additional research into the impacts of medical 
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tourism on patient health and the adequacy of patient information on the risks entailed by 
medical tourism might support these additional regulatory interventions, and is thus needed. 
In interviews, facilitators stated a desire for standardization and regulation as a way to 
professionalize their practice.5 However, it is not clear what organization or group should 
assume this responsibility. Norms and standards of facilitator services have not yet developed, 
no regulatory body has formed to oversee facilitator practices, and a code of practice has not 
been adopted. Medical tourism facilitation companies work in a wide variety of legal and 
regulatory contexts, and without the oversight of one professional accrediting body. The 
international nature of medical tourism, where patients, providers, and facilitators may each 
be based in different countries, makes regulation difficult to impose, especially given the 
significant financial incentives to limit regulatory policies in medical tourism destinations. 
Voluntary participation in an accreditation system akin to JCI accreditation for health 
providers would be a first, feasible step toward greater regulation of the industry. While such 
a system would be voluntary and thus limited in force, JCI accreditation is increasingly seen 
as a de facto requirement for medical tourism providers targeting patients in North America. 
Research Directions 
Our review suggests several areas of research that are needed in order to expand our 
understanding of the ethical dimensions of medical tourism facilitation. Most pressing is an 
understanding of patient-facilitator interactions beyond what is known from public facilitator 
websites. This information will help to bridge several gaps in our understanding of medical 
tourism and of facilitators’ roles and responsibilities. These gaps include the limited 
understanding of the degree to which facilitators convey information on the risks of medical 
tourism, the content and presentation of liability waivers, and discussions of follow-up and 
continuity of care. While ethical concerns about all of these areas are well founded, a better 
understanding of the full range of patient-facilitator interactions will help to add detail to 
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these concerns, illuminate differences in how facilitators interact with their clients, and 
suggest interventions for overcoming or mitigating these concerns. 
 More data are needed on the numbers of medical tourists using facilitators to plan their 
travel abroad for care, medical tourists choosing not to use facilitators, and patients who 
interacted with facilitators but chose not to engage in medical tourism. This data will help to 
better understand patients’ decision-making processes around medical tourism and 
facilitators’ roles and responsibilities in this process. More data also are needed on patient 
outcomes following travel abroad for medical care. This data could help differentiate 
outcomes for those patients using facilitators and help to uncover facilitators’ roles in 
improving or worsening health outcomes for medical tourists. It is possible that these 
outcomes will differ by destination and procedure, and ideally such data would help to 
determine whether facilitators who are accredited and have a medical background have better 
outcomes than other facilitators. 
 Information is greatly needed on how patients, facilitators, and other industry 
stakeholders, including physicians, perceive the facilitators' roles and responsibilities. While 
this information is starting to appear through facilitator interviews, facilitator self-perception 
may vary by location, thus creating the need for comparative insights. Moreover, our 
understanding of patient and other stakeholders’ views of facilitators’ roles and is limited at 
this time. A better understanding of facilitators' roles will help shape regulatory responses and 
inform procedures for facilitator accreditation. 
 Given the dynamic nature of medical tourism and relative newness of facilitation as an 
entrepreneurial venture within this global health services industry, the literature on ethical 
concerns about this practice has been quick to develop. The expanding body of empirically-
based research on facilitation is helping to define our understanding of the ethical dimensions 
of facilitation. Continued research along existing pathways and in the areas described here, 
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while logistically difficult and time- and money-intensive, will help to shape policy responses 
to medical tourism generally and facilitation specifically. Medical tourism facilitation is a 
business that is likely to continue playing a role in securing (or perhaps worsening) patient 
health, thus making it clear that a better understanding of the practice of facilitation and 
diversity of facilitators’ roles and responsibilities toward medical tourists and the industry is 
needed. 
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